预防性家访对老年人医疗与社会服务使用及成本的影响
基于一项随机对照试验(422名75岁以上独居老年人),干预组接受多专业预防性家访。结果显示两组在2年随访期间医疗和社会服务的总使用及成本无显著差异,但干预组健康相关生活质量下降更慢(-0.015),质量调整生命年无显著差异,成本效果平面显示60%的增量成本效果比位于优势象限。
要点
- 多专业预防性家访未增加医疗和社会服务总成本。
- 干预组健康相关生活质量下降更慢,差异为-0.015。
- 两组质量调整生命年无显著差异,60%的增量成本效果比位于优势象限。
核心结论
- 多专业预防性家访对健康相关生活质量有积极影响且不增加额外成本。
研究设计与样本
- 随机对照试验,422名75岁以上独立居家老年人,对照组和干预组人数相等,干预在芬兰一个市镇进行,由多专业人员提供预防性家访。
主要发现
- 两组基线服务使用及2年随访期间医疗和社会服务总使用与成本无显著差异。
- 干预组健康相关生活质量下降显著更慢,差异为-0.015。
- 两组质量调整生命年无显著差异,成本效果平面显示60%的增量成本效果比位于优势象限。
关键数值与推荐
- 使用15D量表测量健康相关生活质量,计算质量调整生命年和增量成本效果比。
临床怎么用
- 可考虑对75岁以上居家老年人实施多专业预防性家访,以延缓健康相关生活质量下降而不增加成本。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We use data from a randomized controlled trial on preventive home visits exploring effectiveness on health-related quality of life. In this article, we examine the intervention's cost-effectiveness and effects on quality-adjusted life years in older home-dwelling adults. METHODS: There were 422 independently home-dwelling participants in the randomized, controlled trial, all aged more than 75 years, with equal numbers in the control and intervention groups. The intervention took place in a municipality in Finland and consisted of multiprofessional preventive home visits. We gathered the data on health care and social services use from central registers and medical records during 1 year before the intervention and 2 years after the intervention. We analyzed the total health care and social services use and costs per person-years and the difference in change in health-related quality of life as measured using the 15D measure. We calculated quality-adjusted life years and incremental cost-effectiveness ratios. RESULTS: There was no significant difference in baseline use of services or in the total use and costs of health care and social services during the 2-year follow-up between the two groups. In the intervention group, health-related quality of life declined significantly more slowly compared with the control group (-0.015), but there was no significant difference in quality-adjusted life years gained between the groups. The cost-effectiveness plane showed 60% of incremental cost-effectiveness ratios lying in the dominant quadrant, representing additional effects with lower costs. CONCLUSIONS: This multiprofessional preventive home visit intervention appears to have positive effects on health-related quality of life without accruing additional costs. THE CLINICAL TRIAL REGISTRATION NUMBER: ACTRN12616001411437.
引用
- Liimatta HA, Lampela P, Kautiainen H, et al. The Effects of Preventive Home Visits on Older People's Use of Health Care and Social Services and Related Costs. J Gerontol A Biol Sci Med Sci. 2020. PMID: 31139827. doi:10.1093/gerona/glz139
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。